CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-10 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −3,470 | $3.00 | $10K | 175,792 |
| 2024-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award | +27,000 | 59,915 | ||
| 2024-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −3,221 | $3.08 | $10K | 56,694 |
| 2024-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,147 | $3.08 | $7K | 54,547 |
| 2024-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2024-01-09 | Flowers Cynthia Louise Director | Grant or award | +19,480 | 49,201 | ||
| 2024-01-09 | BROWN GREGORY B Director | Grant or award | +19,480 | 49,414 | ||
| 2024-01-09 | Mazzo David J Chief Executive Officer | Grant or award | +94,000 | 199,308 | ||
| 2024-01-09 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −12,203 | $3.08 | $38K | 187,105 |
| 2024-01-09 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −7,843 | $3.08 | $24K | 179,262 |
| 2024-01-09 | Mazzo David J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2024-01-09 | AZAB MOHAMMAD Director | Grant or award | +19,480 | 58,680 | ||
| 2024-01-09 | HENSON HEIDI Director | Grant or award | +19,480 | 39,480 | ||
| 2024-01-09 | KLOSK STEVEN M Director | Grant or award | +19,480 | 49,570 | ||
| 2023-09-01 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,908 | $2.18 | $6K | 32,915 |
| 2023-01-13 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −397 | $3.65 | $1K | 96,543 |
| 2023-01-11 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −1,030 | $3.20 | $3K | 96,940 |
| 2023-01-10 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −512 | $3.20 | $2K | 35,823 |
| 2023-01-10 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −3,470 | $3.20 | $11K | 97,970 |
| 2023-01-09 | Slack David W. President & CBO | Grant or award | +24,000 | 24,000 |
Page 4 of 18 · 345 trades